this post was submitted on 16 Dec 2025
1 points (100.0% liked)

China News

72 readers
8 users here now

A community for china news

founded 1 month ago
MODERATORS
rss@news.abolish.capital
Salamence@lemmy.zip
RedWizard@news.abolish.capital
1
Chinese biotech Scizeng’s global licensing deal to yield up to US$1.44 billion (www.scmp.com)
submitted 5 days ago by rss@news.abolish.capital to c/china@news.abolish.capital
0 comments fedilink hide all child comments
 

A Chinese biopharmaceutical firm has sealed a global licensing deal valued at up to US$1.44 billion, the second in a week, as a wave of cross-border tie-ups shows no sign of abating despite headwinds from the US Biosecure Act. Shanghai Scizeng Medical Technology, a unit of Changchun High-Tech Industry, has agreed to grant US-based Yarrow Bioscience exclusive global rights to develop, manufacture and commercialise GenSci098, an injectable therapy for thyroid eye disease and Graves’ disease, both...

From China - South China Morning Post via This RSS Feed.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here